Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Efficacy of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalised adults with COVID-19: a phase 3 double-bind, randomised, placebo-controlled trial (Adaptive COVID-19 Treatment Trial (ACTT-3))
Efficacy of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalised adults with COVID-19: a phase 3 double-bind, randomised, placebo-controlled trial (Adaptive COVID-19 Treatment Trial (ACTT-3)) The Lancet Respiratory Medicine Study team, M. 2021View details for DOI 10.1016/S2213-2600(21)00384-2